Ratings by Goldman Sachs (Evie Koslosky)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/5/2026 | Sotera Health | SHC | New Coverage | Buy (N/A) |
15.27 (18.11) |
18.6% | Details | |
| 6/5/2026 | GRAIL, Inc. | GRAL | New Coverage | Neutral (N/A) |
61.13 (72.70) |
18.93% | Details | |
| 6/5/2026 | Natera | NTRA | New Coverage | Neutral (N/A) |
211.85 (275.19) |
29.9% | Details | |
| 6/5/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
127.03 (159.79) |
25.79% | Details | |
| 4/13/2026 | Revvity Inc | RVTY | Maintain | Neutral (N/A) |
|
Details | ||
| 4/13/2026 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2026 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
17.88 (16.10) |
-9.96% | Details | |
| 2/27/2026 | Agilent | A | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Bruker | BRKR | Maintain | Sell (N/A) |
|
Details | ||
| 12/9/2025 | Bruker | BRKR | New Coverage | Sell (N/A) |
48.03 (50.30) |
4.73% | Details | |
| 12/9/2025 | Mettler-Toledo | MTD | New Coverage | Neutral (N/A) |
1414.86 (1437.00) |
1.56% | Details | |
| 12/9/2025 | Revvity Inc | RVTY | New Coverage | Neutral (N/A) |
100.79 (111.39) |
10.52% | Details | |
| 12/9/2025 | Danaher | DHR | New Coverage | Buy (N/A) |
226.25 (194.78) |
-13.91% | Details | |
| 12/9/2025 | Agilent | A | New Coverage | Buy (N/A) |
145.49 (139.20) |
-4.32% | Details | |
| 12/9/2025 | Thermo Fisher Scientific | TMO | New Coverage | Buy (N/A) |
572.77 (564.75) |
-1.4% | Details |
